专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08871218B2 Infant nutritional compositions for preventing obesity 有权
标题翻译：用于预防肥胖症的婴儿营养组合物
公开(公告)号：US08871218B2
公开(公告)日：2014-10-28
申请号：US13357109
申请日：2012-01-24
申请人： Renate Maria Louise Zwijsen , Gelske Speelmans , Eline Marleen van der Beek , Gunther Boehm
发明人： Renate Maria Louise Zwijsen , Gelske Speelmans , Eline Marleen van der Beek , Gunther Boehm
IPC分类号： A61K36/02 , A61K31/70 , A61K31/20 , A23L1/29 , A61K31/198 , A23L1/30 , A61K35/20 , A61K31/185
CPC分类号： A61K38/1709 , A23L33/12 , A23L33/40 , A23V2002/00 , A61K31/14 , A61K31/185 , A61K31/198 , A61K31/20 , A61K31/201 , A61K31/202 , A61K31/575 , A61K31/688 , A61K31/7016 , A61K31/702 , A61K35/20 , A23V2250/1882 , A23V2250/1878 , A23V2250/54246 , A23V2250/612 , A23V2250/28 , A23V2250/1846
摘要： The present invention relates to a method for preventing obesity later in life by administering a certain nutritional composition to an infant between 0 and 36 months of age.
摘要翻译：本发明涉及通过对0至36个月龄的婴儿施用某种营养组合物来预防生命后期的肥胖的方法。

2. 发明申请

US20090156487A1 INFANT NUTRITIONAL COMPOSITIONS FOR PREVENTING OBESITY 有权
标题翻译：用于预防肥胖的婴儿营养组合物
公开(公告)号：US20090156487A1
公开(公告)日：2009-06-18
申请号：US12158876
申请日：2006-12-22
申请人： Renate Maria Louise Zwijsen , Gelske Speelmans , Eline Marleen van de Beek , Gunther Boehm
发明人： Renate Maria Louise Zwijsen , Gelske Speelmans , Eline Marleen van de Beek , Gunther Boehm
IPC分类号： A23L1/29 , A23L1/30 , A61K38/16 , A61P3/04 , A61P9/00 , A61P9/10
CPC分类号： A61K31/202 , A23L33/12 , A23L33/15 , A23L33/16 , A23L33/17 , A23L33/40 , A23V2002/00 , A61K31/185 , A61K31/198 , A61K31/20 , A61K33/24 , A61K33/32 , A61K35/20 , A61K45/06 , A61K2300/00 , A23V2250/161 , A23V2250/1608 , A23V2250/302 , A23V2250/28 , A23V2250/70 , A23V2250/72 , A23V2250/705 , A23V2250/54252 , A23V2250/54246 , A23V2250/194 , A23V2200/332 , A23V2250/5488 , A23V2250/061 , A23V2250/0624 , A23V2250/1868 , A23V2250/187 , A23V2250/0616 , A23V2250/1618 , A23V2250/7052 , A23V2250/7056 , A23V2250/706 , A23V2250/1612 , A23V2250/5114 , A23V2250/628 , A23V2250/712 , A23V2250/708 , A23V2250/1626 , A23V2250/1642 , A23V2250/714 , A23V2200/328 , A23V2250/548 , A23V2250/608 , A23V2250/62 , A23V2250/5118 , A23V2250/5108 , A23V2250/218 , A23V2250/156 , A23V2200/304 , A23V2250/0644 , A23V2250/304 , A23V2250/1842
摘要： The present invention relates to a method for preventing obesity later in life by administering a certain nutritional composition to an infant with the age between 0 and 36 months. The composition comprises linoleic and alpha-linolenic acid.
摘要翻译：本发明涉及通过对年龄在0至36个月之间的婴儿施用某种营养组合物来预防生命后期的肥胖的方法。组合物包含亚油酸和α-亚麻酸。

3. 发明申请

US20110136732A1 INFANT NUTRITIONAL COMPOSITIONS FOR PREVENTING OBESITY 审中-公开
标题翻译：用于预防肥胖的婴儿营养组合物
公开(公告)号：US20110136732A1
公开(公告)日：2011-06-09
申请号：US12158857
申请日：2006-12-22
申请人： Gunther Boehm , Johannes Wilhelmus Christina Sijben , Renate Maria Louise Zwijsen
发明人： Gunther Boehm , Johannes Wilhelmus Christina Sijben , Renate Maria Louise Zwijsen
IPC分类号： A61K38/00 , A61P3/04
CPC分类号： A61K38/1709 , A23L33/12 , A23L33/125 , A23L33/40 , A23V2002/00 , A61K31/14 , A61K31/185 , A61K31/198 , A61K31/20 , A61K31/201 , A61K31/202 , A61K31/575 , A61K31/688 , A61K31/7016 , A61K31/702 , A61K35/20 , A23V2250/1882 , A23V2250/1878 , A23V2250/54246 , A23V2250/612 , A23V2250/28 , A23V2250/1846
摘要： The present invention relates to a method for preventing obesity later in life by administering a certain nutritional composition to an infant with the age between 0 and 36 months. The composition comprises linoleic acid and alpha-linolenic acid.
摘要翻译：本发明涉及通过对年龄在0至36个月之间的婴儿施用某种营养组合物来预防生命后期的肥胖的方法。组合物包含亚油酸和α-亚麻酸。

4. 发明授权

US08729123B2 Nutrition containing fat blend 有权
标题翻译：营养含脂肪混合物
公开(公告)号：US08729123B2
公开(公告)日：2014-05-20
申请号：US13251399
申请日：2011-10-03
申请人： Bernd Stahl , Gunther Boehm , Christopher Beermann , Johan Garssen
发明人： Bernd Stahl , Gunther Boehm , Christopher Beermann , Johan Garssen
IPC分类号： A61K31/22 , A61K31/20
CPC分类号： A61K31/202 , A23L33/12 , A23L33/22 , A23L33/40 , A23V2002/00 , A23V2250/187 , A23V2250/1868 , A23V2250/5046 , A23V2250/1872 , A23V2250/1874 , A23V2250/0644 , A23V2250/1642
摘要： The invention relates to the use of long chain polyunsaturated fatty acids for the manufacture of a nutritional composition for feeding infants of a mother who suffered from a metabolic disorder during pregnancy and to a corresponding composition. Said composition comprises a n-3 polyunsaturated fatty acid fraction containing at least 0.1 wt % docosahexaenoic acid (DHA) based on total weight of the lipid, at least 0.01 wt % n-3 docosapentaenoic acid (DPAn-3) based on total weight of the lipid, and at least 0.01 wt. % eicosapentaenoic acid (EPA) based on total weight of the lipid, wherein the sum of DHA, DPAn-3 and EPA is below 1 wt. % of total lipid.
摘要翻译：本发明涉及长链多不饱和脂肪酸用于制造用于喂养怀孕期间代谢紊乱的母亲的婴儿的营养组合物和相应组合物的用途。所述组合物包含n-3多不饱和脂肪酸级分，其含有基于脂质总重量的至少0.1重量％二十二碳六烯酸（DHA），至少0.01重量％的n-3二十二碳五烯酸（DPAn-3），基于脂质和至少0.01重量％基于脂质总重量的二十碳五烯酸（EPA），其中DHA，DPAn-3和EPA的总和低于1wt。总脂质的百分比。

5. 发明授权

US07919479B2 Antiadhesive carbohydrates 有权
标题翻译：防粘碳水化合物
公开(公告)号：US07919479B2
公开(公告)日：2011-04-05
申请号：US11511500
申请日：2006-08-29
申请人： Bernd Stahl , Gunther Boehm
发明人： Bernd Stahl , Gunther Boehm
IPC分类号： A61K31/702 , A61K31/733 , A61K31/732
CPC分类号： A61K31/7012 , A23L5/00 , A23L29/231 , A23L29/256 , A23L29/30 , A23L33/00 , A23L33/10 , A23L33/125 , A61K31/702 , A61K31/715
摘要： Provided is a pharmaceutical or dietetic product, which serves for reducing and/or blocking the adhesion of pathogenic substances and organisms to eucaryontic cells, in particular mammal cells. Said preparation contains at least one carbohydrate having an uronic acid unit on one of the ends thereof. 10 to 100% of the present, terminal uronic acid units pertaining to the carbohydrates are provided with a double bond that is especially situated between the C4 and C5 atom.
摘要翻译：提供了一种药物或饮食产品，其用于减少和/或阻断致病物质和生物体对真核细胞特别是哺乳动物细胞的粘附。所述制剂包含至少一种在其一个端部具有糖醛酸单元的碳水化合物。本发明的碳原子数为10〜100％的末端糖醛酸单元具有特别位于C4和C5原子之间的双键。

6. 发明授权

US07850460B2 Electrical contact element for contacting an electrical component under test and contacting apparatus 有权
标题翻译：用于接触被测电气部件和接触装置的电接触元件
公开(公告)号：US07850460B2
公开(公告)日：2010-12-14
申请号：US12463083
申请日：2009-05-08
申请人： Achim Weiland , Gunther Boehm
发明人： Achim Weiland , Gunther Boehm
IPC分类号： H01R12/00
CPC分类号： G01R1/06733 , G01R1/0675 , G01R1/07357 , H01R13/2407 , H01R13/2435 , H01R2201/20
摘要： An elongate electrical contact element (1) for physically contacting electrical components under test, having two electrical contacting end regions (2, 3) and an elongate intermediate region (4) situated between the end regions (2, 3). The intermediate region (4) has an essentially rectangular cross-section and is configured lamellar along its longitudinal extent. Also disclosed is a corresponding contacting apparatus (22) including such a contact element (1) and a contact element holder (23).
摘要翻译：用于物理接触待测电气部件的细长电接触元件（1），具有两个电接触端区域（2,3）和位于端部区域（2,3）之间的细长中间区域（4）。中间区域（4）具有基本上矩形的横截面，并且沿其纵向范围被构造成层状。还公开了包括这种接触元件（1）和接触元件保持器（23）的相应接触装置（22）。

7. 发明授权

US07498318B1 Food for diabetics 失效
标题翻译：糖尿病食物
公开(公告)号：US07498318B1
公开(公告)日：2009-03-03
申请号：US10129095
申请日：2000-11-10
申请人： Bernd Stahl , Michael Kliem , Sandra Farwer , Gunther Sawatzki , Gunther Boehm
发明人： Bernd Stahl , Michael Kliem , Sandra Farwer , Gunther Sawatzki , Gunther Boehm
IPC分类号： A61K31/718
CPC分类号： C12Y204/01019 , A23L5/00 , A23L29/30 , A23L33/125 , A23L33/20 , A23L33/21 , C12P19/14 , C12P19/18 , C12Y204/01024
摘要： Provided is a carbohydrate mixture comprising at least one modified carbohydrate from a base body and a carbohydrate residue coupled therewith. The base body concerned is either a digestible glucose-containing carbohydrate in the form of a digestible glucan or a non-digestible reserve carbohydrate, skeletal carbohydrate or a low-molecular component thereof. By coupling the base body with a carbohydrate residue, the glucose release from the inventive carbohydrate mixture is reduced by at least 10%, determined in an in-vivo digestion system on the basis of pancreatine and compared with a carbohydrate mixture containing the same amount by weight of non-modified carbohydrates. By means of the inventive carbohydrate mixture, the postprandial blood glucose concentration after eating can be moderated. The glucose can thus be metabolized by diabetics in spite of the existing lack of insulin. The inventive carbohydrate mixtures can be used in food for diabetics and in pharmaceuticals.
摘要翻译：提供了包含至少一种来自碱体的修饰的碳水化合物和与其偶联的碳水化合物残基的碳水化合物混合物。所涉及的基体是可消化葡萄糖或不可消化的储备碳水化合物，骨骼碳水化合物或其低分子组分形式的可消化的含葡萄糖的碳水化合物。通过将基体与碳水化合物残基偶联，将本发明的碳水化合物混合物的葡萄糖释放量减少至少10％，在基于胰腺的体内消化系统中测定，并与含有相同量的碳水化合物混合物非改性碳水化合物的重量。通过本发明的碳水化合物混合物，饮食后餐后血糖浓度可以缓和。糖可以由糖尿病代谢，尽管目前缺乏胰岛素。本发明的碳水化合物混合物可用于糖尿病患者和药物中。

8. 发明授权

US09078466B2 Composition to treat and/or prevent gastrointestinal infection 有权
标题翻译：用于治疗和/或预防胃肠道感染的组合物
公开(公告)号：US09078466B2
公开(公告)日：2015-07-14
申请号：US12311694
申请日：2007-09-20
申请人： Gunther Boehm , Jaochim Schmitt , Gilda Georgi , Marco Euler
发明人： Gunther Boehm , Jaochim Schmitt , Gilda Georgi , Marco Euler
IPC分类号： A61K36/48 , A61K36/00 , A61K35/20 , A23L1/305
CPC分类号： A23L1/3056 , A23L33/18 , A23L33/185 , A23L33/19 , A61K35/20 , A61K36/48 , Y02A50/473 , Y02A50/481 , A61K2300/00
摘要： The invention relates to a composition for the treatment and/or prevention of infection by gastrointestinal pathogens, in particular Helicobacter pylori and/or a disease associated with infection by said gastrointestinal pathogen in mammals.
摘要翻译：本发明涉及用于治疗和/或预防胃肠道病原体感染的组合物，特别是幽门螺杆菌和/或与哺乳动物中所述胃肠道病原体感染相关的疾病。

9. 发明申请

US20080096794A1 Peptide Mixture From Peptides Having A Molecular Weight Of from 1000 To 5000 Dalton 审中-公开
标题翻译：具有分子量为1000至5000道尔顿的肽的肽混合物
公开(公告)号：US20080096794A1
公开(公告)日：2008-04-24
申请号：US11660595
申请日：2005-08-12
申请人： Gunther Boehm , Christopher Beermann , Bernd Stahl , Gilda Georgi , Joachim Schmitt , Nadine Bock , Sorge Kelm
发明人： Gunther Boehm , Christopher Beermann , Bernd Stahl , Gilda Georgi , Joachim Schmitt , Nadine Bock , Sorge Kelm
IPC分类号： A61K38/00 , A23C9/00 , A23J3/08 , A61P43/00 , C07K16/00 , A23J3/10 , A23L1/305
CPC分类号： A23J3/346 , A23J3/344 , A23L33/18 , A23L33/40 , A61K35/20 , A61K36/06 , A61K36/31 , A61K36/48 , A61K36/88 , A61K38/168 , A61K38/1709 , A61K2300/00
摘要： The invention relates to the use of a peptide mixture comprising peptides with a molecular weight from 1000 to 5000 Daltons for the prevention and/or treatment of tumour diseases, of diseases which are associated with a development disorder of the immune system, of diseases of the immune system, of autoimmune reactions, of allergies and of inflammation in man, a protein component which contains such a peptide mixture and a formula food containing this peptide mixture. The peptides are preferably obtained from non-human proteins suitable for nutritional purposes, in particular by the enzymatic or hydrolytic cleavage of these proteins.
摘要翻译：本发明涉及包含分子量为1000至5000道尔顿的肽的肽混合物在预防和/或治疗与免疫系统发育障碍相关的疾病的肿瘤疾病中的用途，免疫系统，自身免疫反应，过敏和人类炎症，含有这种肽混合物的蛋白质组分和含有该肽混合物的配方食品。肽优选地从适合于营养目的的非人蛋白质获得，特别是通过这些蛋白质的酶促或水解切割。

10. 发明申请

US20050089969A1 Insulin mimetic amino acid sequences 审中-公开
标题翻译：胰岛素模拟氨基酸序列
公开(公告)号：US20050089969A1
公开(公告)日：2005-04-28
申请号：US10476184
申请日：2002-10-07
申请人： Josef Wissler , Gilda Georgi , Gunther Boehm
发明人： Josef Wissler , Gilda Georgi , Gunther Boehm
IPC分类号： C07K14/62 , A61K38/00 , A61K38/28 , A61K38/30 , A61P5/48 , C07K14/415 , C07K14/47 , C07K14/475 , C12N15/17 , C07H21/04
CPC分类号： C07K14/415 , A61K38/00 , C07K14/4732
摘要： The invention relates to exsulins or insulin mimetic amino acid sequences with a molecular weight of up to 55,000 daltons and with 1 to 50 basic units of following Formula (1): [−] L,V,I,A]-X1—X2-[L,V,I,A]-[D,E]-[N,Q,M]-X3—[C,H]—X4 [−], whereby; [L,V,I,A], [D,E], [N,Q,M], [C,H] and X1 to 4 represent peptidically linked amino acids; [L,V,I,A] represents leucine (L), valine (V), isoleucine (I) or alanine (A); [D,E] represents asparaginic acid (D) or glutamic acid (E); [N,Q,M] represents asparagine (N), glutamine (Q) or methionine (M); [C,H] represents cysteine (C) or histidine (H); both groups [L,V,I,A] in a basic unit can be identical or different; X1, X2, X3 and X4 represent any type of amino acid and the four amino acids X1 to 4 in a basic unit can be identical or different. The inventive exsulins can be used in dietetic and pharmaceutical agents, and to be precise, can be used for mimicking the properties and functions of members of the family of endogenous insulin and IGF proteohormones/mediators and for preventing, treating and influencing hormonal states and disturbances as well as various degenerative diseases of the body of mammals including various forms of hormonal metabolic disturbances, hormonal resistances, hormonal deficiencies, hyperinsulinemia, diabetes mellitus and autoimmune diseases as well as neurodegenerative and secondary diseases.
摘要翻译：本发明涉及分子量高达55,000道尔顿的exsulins或胰岛素模拟氨基酸序列，以及具有1至50个下式（1）的基本单位：[ - ] L，V，I，A] -X < 1 2 - [L，V，I，A] - [D，E] - [N，Q，M] -X 3 - [C，H] -X 4 - [ - ]，由此; [L，V，I，A]，[D，E]，[N，Q，M]，[C，H]和X 1〜4代表肽连接的氨基酸; [L，V，I，A]表示亮氨酸（L），缬氨酸（V），异亮氨酸（I）或丙氨酸（A） [D，E]表示天冬氨酸（D）或谷氨酸（E）; [N，Q，M]表示天冬酰胺（N），谷氨酰胺（Q）或甲硫氨酸（M）; [C，H]表示半胱氨酸（C）或组氨酸（H）; 基本单元中的两组[L，V，I，A]可以相同或不同; X 1，X 2，X 3和X 4代表任何类型的氨基酸，并且四个氨基酸基本单元中的X 1〜4可以相同或不同。本发明的exsulins可以用于饮食和药物，并且精确地可以用于模拟内源胰岛素和IGF蛋白激素/介体家族成员的性质和功能，并用于预防，治疗和影响荷尔蒙状态和干扰以及哺乳动物身体的各种退行性疾病，包括各种形式的激素代谢紊乱，激素抵抗，激素缺乏症，高胰岛素血症，糖尿病和自身免疫疾病以及神经变性和继发性疾病。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式